Alembic Pharma Share Jumps 5% After USFDA Approves Glaucoma Drug
Shares of Alembic Pharmaceuticals rose 5% in early trading on March 31 after receiving final approval from the US Food and Drug Administration (USFDA) for...
Download Unicorn Signals App
Powered By EquityPandit
